$ELAN Cashflow Statement | Understand Stock

$ELAN

$22.65 -$0.31 (1.35%) Close

$ELAN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities
Net (loss) income
Adjustments to reconcile net (loss) income to cash flows from operating activities:
Depreciation and amortization
Goodwill impairment
Deferred income taxes
Stock-based compensation expense
Asset impairment and write-down charges
Loss (gain) on sale of assets
Inventory fair value step-up amortization
Gain on divestiture
Loss on extinguishment of debt
Proceeds from interest rate swap settlements
Sold portion of royalty revenue
Interest on liability for sale of future revenue
Other non-cash operating activities, net
Other changes in operating assets and liabilities, net of acquisitions and divestitures:
Receivables
Inventories
Other assets
Accounts payable and other liabilities
Other changes in operating assets and liabilities

Net Cash Provided by Operating Activities
Cash Flows from Investing Activities
Net purchases of property and equipment and software
Disposals of property and equipment
Purchases of software
Purchases of intangible assets
Cash paid for acquisitions
Divestiture proceeds
Proceeds from divestitures
Proceeds from sale of Shawnee and Speke facilities
Other investing activities, net
Net Cash (Used for) Provided by Investing Activities

Cash Flows from Financing Activities
Proceeds from facility
Revolving Credit Facility
Securitization Facility
Total proceeds from facility

Repayments of facility
Revolving Credit Facility
Securitization Facility
Total repayments of facility

Debt issuance costs
Consideration paid to Lilly in connection with the separation
Early redemption and tender premiums paid
Proceeds from issuance of long-term debt
Repayments of long-term borrowings
Funding related to construction of corporate headquarters
Proceeds from sale of future revenue, net of transaction costs
Other financing activities, net
Net Cash Used for Financing Activities

Effect of exchange rate changes on cash and cash equivalents
Net increase in cash and cash equivalents
Cash and cash equivalents at January 1
Cash and cash equivalents at December 31

Comments